Publication Name	World Journal of Virology
Manuscript ID	12943
Country	United States

Received	2014-07-29 11:09
Peer-Review Started	2014-07-29 17:25
First Decision by Editorial Office Director
Return for Revision	2014-11-03 08:46
Revised	2014-11-11 07:30
Publication Fee Transferred
Second Decision by Editor	2014-11-14 20:18
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2014-11-19 11:17
Articles in Press	2014-11-19 11:17
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-01-19 14:00
Publish the Manuscript Online	2015-01-20 22:09

ISSN	2220-3249 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Virology
Manuscript Type	Minireviews
Article Title	What psychiatric screening and monitoring might be needed with the new generation of hepatitis C treatments?
Manuscript Source	Invited Manuscript
All Author List	Paul J Rowan
Funding Agency and Grant Number
Corresponding Author	Paul J Rowan, PhD, MPH, University of Texas Health Sciences Center at Houston School of Public Health, 1200 Herman Pressler Drive, Houston, TX 77030, United States. prowan@uth.tmc.edu
Key Words	Depression; Therapy; Psychiatry; Review; Clinical
Core Tip	Emerging hepatitis C treatment regimens, which include newer medications such as boceprevir, telaprevir, sofosbuvir, and simeprevir, hold promise to reduce the need for psychosocial screening and monitoring. Thus far, these medications do not seem to have the same psychiatric side effect profile as interferon-alpha.
Publish Date	2015-01-20 22:09
Citation	Rowan PJ. What psychiatric screening and monitoring might be needed with the new generation of hepatitis C treatments? World J Virol 2015; 4(1): 13-16
URL	http://www.wjgnet.com/2220-3249/full/v4/i1/13.htm
DOI	http://dx.doi.org/10.5501/wjv.v4.i1.13

Full Article (PDF)	WJV-4-13.pdf
Full Article (Word)	WJV-4-13.doc
Manuscript File	12943-Review.docx
Answering Reviewers	12943-Answering reviewers.pdf
Biostatistics Review Certificate	Biostatistician_Review_Report_20140729103714.docx
Copyright License Agreement	12943-Copyright assignment.pdf
Institutional Review Board Approval Form or Document	Ethics_Committee_20140729103638.docx
Peer-review Report	12943-Peer review(s).pdf
Scientific Misconduct Check	12943-CrossCheck.jpg
Scientific Editor Work List	12943-Scientific editor work list.pdf